Molecular evidence suggesting the persistence of residual SARS‐CoV‐2 and immune responses in the placentas of pregnant patients recovered from COVID‐19
Cell Proliferation2021Vol. 54(9), pp. e13091–e13091
Citations Over TimeTop 10% of 2021 papers
Hao Wu, Shujie Liao, Yiming Wang, Ming Guo, Xingguang Lin, Jianli Wu, R. Wang, Dan Lv, Di Wu, Mengzhou He, Bai Hu, Rui Long, Jing Peng, Hui Yang, Heng Yin, Xin Wang, Zhixiang Huang, Ke Lan, Yanbin Zhou, Wei Zhang, Zhenyu Xiao, Yun Zhao, Dongrui Deng, Hongmei Wang
Abstract
Our study showed that SARS-CoV-2 nucleic acid (in one patient) and protein (in five patients) were present in the placentas of clinically recovered pregnant patients for more than 3 months after diagnosis. The immune responses induced by the virus may lead to prolonged and persistent symptoms in the maternal plasma, placenta, umbilical cord, cord blood and amniotic fluid.
Related Papers
- → Accumulation of cadmium in human placenta interacts with the transport of micronutrients to the fetus(2009)222 cited
- → What to do with placenta after birth: is it a waste?(2021)1 cited
- → Cord Blood Banking for Stem Cell Transplant(1993)9 cited
- The clinical observation bleeding the umbilical cord blood to accelerate the placenta separation(2006)
- → Placenta and Umbilical Cord(2016)